NCT06184815

Brief Summary

This trial compared an structured education programme and multidisciplinary treatment vs an standard treatment in type 1 diabetes patient, the Primary outcome is glycemic control at 6-month follow up and secondary outcome are cardiovascular risk factors control, diabetes related distress, anxiety and depressive symptoms, hypoglycemia awareness.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 28, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

December 28, 2023

Status Verified

December 1, 2023

Enrollment Period

10 months

First QC Date

December 15, 2023

Last Update Submit

December 15, 2023

Conditions

Keywords

type 1 diabetesAutoimmune DiseasesDiabetesEducation ProgrammeDSMESDiabetes self-management education and supportT1DInsulin-dependent diabetesJuvenile diabetes

Outcome Measures

Primary Outcomes (1)

  • Changes in Glycemic Control Measured by A1c

    Difference between baseline A1c and A1c at 6 month follow up

    Baseline and 6 months

Secondary Outcomes (5)

  • Changes in Lipid Control Measured by LDLc, HDLc, non-HDLc, Triglycerides, Total Cholesterol

    Baseline and 6 months

  • Changes in insulin resistance control Measured by eGDR

    Baseline and 6 months

  • Changes in Mental health Measured by DDS, GAD7 and PHQ9

    Baseline and 6 months

  • Changes Anthropometry Measured by BMI and WC

    Baseline and 6 months

  • Changes in Glycemic Control Measured by severe hypoglycemia

    Baseline and 6 months

Study Arms (2)

Educational programme 12

EXPERIMENTAL

The educational programme consists of 12 lessons, diabetes education slides and patient materials, with a duration of 4 months. The multidisciplinary treatment consists of 4, each one every month, consultations of specialties of nutrition, endocinrology and psychology.

Behavioral: Educational programme 12

Standard

ACTIVE COMPARATOR

The standard educational program consists of outpatient management with diabetic education slides and material for the patient, with a duration of 4 months. Standard treatment consists of endocrinology consultation with nutrition and psychology referral if required

Behavioral: Standard education and treatment

Interventions

Consists of 12 lessons, diabetes education slides and patient materials, with a duration of 4 months and multidisciplinary treatment

Educational programme 12

Outpatient management and education in the office and consultation referral to nutrition and psychology

Also known as: Standard
Standard

Eligibility Criteria

Age15 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Type 1 diabetes
  • Diabetes duration \>1 year
  • BMI 18.5-40kg/m2
  • A1c 6.5-13%

You may not qualify if:

  • Pregnancy
  • Dementia or severe cognitive impairment
  • Uncontrolled psychiatric disorder
  • Absence of \>20% of the educational sessions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Autoimmune DiseasesDiabetes Mellitus

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesImmune System Diseases

Study Officials

  • David Sanchez, MD

    Centro Médico Nacional del Noreste Hospital de Especialidades UMAE 25 Monterrey, Mexico

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Sanchez, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
The standard educational and treatment program consists of outpatient management and education in the office and consultation referral to nutrition and psychology with a duration of 4 months.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The educational programme consists of 12 lessons, diabetes education slides and patient materials, with a duration of 4 months. The multidisciplinary treatment consists of 4, each one every month, consultations of specialties of nutrition, endocinrology and psychology.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 15, 2023

First Posted

December 28, 2023

Study Start

January 1, 2024

Primary Completion

November 1, 2024

Study Completion

November 30, 2024

Last Updated

December 28, 2023

Record last verified: 2023-12